Can adenocarcinoma in situ of the uterine cervix be predicted before cervical conization?

Asian Pacific Journal of Cancer Prevention

Volumn 7, Issue 4, 2006, Pages 522-524

  Kietpeerakool, Chumnan ^a   Srisomboon, Jatupol ^a   Prompittayarat, Wiboonwan ^a   Kanjanavaha, Panida ^b   Peuwsai, Ream ^b   Dheerakul, Chudsuda ^b  

^a CHIANG MAI UNIVERSITY   (Thailand)

^b Faculty of Medicine Chiang Mai University   (Thailand)

Author keywords

Adenocarcinoma in situ; Biopsy; Cervical conization; Cytology

Indexed keywords

ADENOCARCINOMA; ADULT; ARTICLE; BIOPSY; CARCINOMA IN SITU; COLPOSCOPY; CURETTAGE; FEMALE; HUMAN; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX; UTERINE CERVIX CONIZATION; UTERINE CERVIX TUMOR; VAGINA SMEAR;

ADENOCARCINOMA; ADULT; BIOPSY; CARCINOMA IN SITU; CERVIX UTERI; COLPOSCOPY; CONIZATION; DILATATION AND CURETTAGE; FEMALE; HUMANS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 33947514224     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Azodi M, Chambers SK, Rutherford TJ, et al (1999). Adenocarcinoma in situ of the cervix: management and outcome. Gynecol Oncol, 73, 348-53.
2. Castellsague X, Diaz M, de Sanjose S, et al (2006): International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst, 98, 303-15.
3. Denehy TR, Gregori CA, Breen JL (1997). Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix. Obstet Gynecol, 90, 1-6.
4. Duggan MA, Benoit JL, McGregor SE, et al (1994). Adenocarcinoma in situ of the endocervix: human papillomavirus determination by dot blot hybridization and polymerase chain reaction amplification. Int J Gynecol Pathol, 13, 143-9.
5. Mathevet P, Dargent D, Roy M, Beau G (1994). A randomized prospective study comparing three techniques of conization: cold knife, laser, and LEEP. Gynecol Oncol, 54, 175-9.
6. Mitchell H, Higgins V (1994). Recent negative cytology prior to histologically confirmed carcinoma in situ of the cervix. Aust N Z J Obstet Gynaecol, 34, 178-81.
7. Schoolland M, Segal A, Allpress S, Miranda A, Frost FA, Sterrett GF (2002). Adenocarcinoma in situ of the cervix. Cancer, 96, 330-7.
8. Tavassoli FA, Devilee P (2003). World Health Organization Classification of Tumours. Pathology and genetics of tumours of the breast and female genital organs. Lyon: IARC Press
9. Vizcaino AP, Moreno V, Bosch FX, et al (1998). International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas. Int J Cancer, 75, 536-45.
10. Vizcaino AP, Moreno V, Bosch FX, et al (2000). International trends in incidence of cervical cancer: II. Squamous-cell carcinoma. Int J Cancer, 86, 429-35.
11. Wang SS, Sherman ME, Hildesheim A, Lacey JV Jr, Devesa S (2004). Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000. Cancer, 100, 1035-44.
12. Wildrich T, Kennedy AW, Myers TM, Hart WR, Wirths S (1996). Adenocarcinoma in situ of the uterine cervix: management and outcome. Gynecol Oncol, 61, 304-8.
13. Wolf JK, Levenback C, Malpica A, Morris M, Burke T, Mitchell MF (1996). Adenocarcinoma in situ of the cervix: significance of cone biopsy margins. Obstet Gynecol, 88, 82-6.
14. Zaino RJ (2002). Symposium part I: adenocarcinoma in situ, glandular dysplasia, and early invasive adenocarcinoma of the uterine cervix. Int J Gynecol Pathol, 21, 314-26.